Drug search by name

Encorafenib and Hepatic impairment

Result of checking the interaction of drug Encorafenib and disease Hepatic impairment for safety when used together.

Check result:

Encorafenib <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

A recommended dose of encorafenib has not been established for patients with moderate (Child-Pugh Class B) or severe (Child-Pugh Class C) hepatic impairment. Caution and monitoring is advised if used on these patients. Dose adjustment for is not recommended in patients with mild hepatic impairment (Child-Pugh Class A).

Encorafenib

Generic Name: encorafenib

Brand Name: Braftovi

Synonyms: n.a.

What is Encorafenib?